Interacting Drugs |
Eplerenone vs CYP3A4 Inhibitors (Moderate) |
Security Level |
|
Mechanism |
CYP3A4 Inhibitors (Moderate): May increase the serum concentration of Eplerenone. |
Management |
A lower starting dose of eplerenone (25 mg once daily for adults) is recommended in patients with hypertension who are also taking drugs that are moderate inhibitors of CYP3A4. |
Eplerenone vs CYP3A4 Inhibitors (Moderate)
Post Review about Eplerenone vs CYP3A4 Inhibitors (Moderate) Click here to cancel reply.
Other Interactions of Eplerenone
Other Interactions of CYP3A4 Inhibitors (Moderate)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.